Q32 Bio
Business Services · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
830 Winter St Fl 2, Waltham, Minnesota, ...Phone Number
(781) 999-0232Website
www.q32bio.comRevenue
$53.7 MillionStock Symbol
QTTBIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
2
1
1
1
About Q32 Bio
Q32 Bio is a clinical-stage biotechnology company focused on developing innovative therapies for autoimmune and inflammatory diseases. The company leverages advances in immunology to create treatments that aim to restore balanced immune function and address the underlying causes of chronic immune-mediated conditions. Its research centers on targeted biologic approaches designed to improve patient outcomes while minimizing unwanted immune effects. Q32 Bio is advancing a pipeline of therapeutic candidates through clinical development.Explore more
Q32 Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Q32 Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Q32 Bio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Q32 Bio has new funding data
Check out if Q32 Bio is spiking on competitors!
Earning: See what the market has to say on Q32 Bio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Q32 Bio
Check if Q32 Bio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Q32 Bio launches new products
Website visits: Recent activity has been detected on your website
Q32 Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Q32 Bio
Find 2 more new buyers
Compare Similar Companies to Q32 Bio
Compare insights from companies similar to Q32 Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Q32 Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Q32 Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Q32 Bio.
Q32 Bio financials insights
Gather financial insights about Q32 Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$46M
Series B
$60M
2026
Stock/Share Issuance
$55M
Q32 Bio Tech Stack
A closer look at the technologies used by Q32 Bio
Most Recent Scoops
Funding
Funding
Earnings
Earnings, Finance
Project
Laboratory Operations, Medical Research, Clinical Operations
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Q32 Bio News & Media
Why Q32 Bio Stock Skyrocketed Today
The biotech is advancing a potential treatment for a common autoimmune disease.Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata
-- Clinically meaningful efficacy data on the primary endpoint was observed with a mean percent reduction in SALT score from baseline of 35.3% in the prespecified mITT analysis -- -- 40.0% of patients achieved SALT-20 response at Week 36 in the mITT analysis and 30.3% of patients achieved...Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026
-- Conference call to be held Monday, July 13th at 8:00 a.m. E.T. -- WALTHAM, Mass., July 10, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and...Q32 Bio Secures $55 Million Private Placement to Advance Alopecia Areata Pipeline (QTTB)
Q32 Bio raised approximately $55 million in a private placement led by major healthcare investors as the company continues development of its Phase 2 alopecia areata therapy program. Key Investor TakeawaysQ32 Bio (NASDAQ:QTTB) announced a $55 million private placement involving institutional and accredited investors.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Q32 Bio
Sign Up For FreeTo access detailed company insights
Q32 Bio is a clinical-stage biotechnology company focused on developing innovative therapies for autoimmune and inflammatory diseases. The company leverages advances in immunology to create treatments that aim to restore balanced immune function and address the underlying causes of chronic immune-mediated conditions. Its research centers on targete... Read More
